Arvinas, Inc. (ARVN)
12.15
+0.08
(+0.66%)
USD |
NASDAQ |
Jan 12, 16:00
12.15
0.00 (0.00%)
After-Hours: 20:00
Arvinas Research and Development Expense (Quarterly): 64.30M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Alnylam Pharmaceuticals, Inc. | 358.81M |
| Verastem, Inc. | 28.99M |
| Genprex, Inc. | 2.193M |
| Olema Pharmaceuticals, Inc. | 39.95M |